Transcranial Magnetic Stimulation for the Treatment of Concussion: A Systematic Review.


Journal

Neuromodulation : journal of the International Neuromodulation Society
ISSN: 1525-1403
Titre abrégé: Neuromodulation
Pays: United States
ID NLM: 9804159

Informations de publication

Date de publication:
Jul 2021
Historique:
revised: 11 10 2020
received: 03 08 2020
accepted: 26 10 2020
pubmed: 14 11 2020
medline: 19 8 2021
entrez: 13 11 2020
Statut: ppublish

Résumé

Post-concussive symptoms (PCSs) are common, disabling, and challenging to manage. Evolving models of concussion pathophysiology suggest evidence of brain network dysfunction that may be amenable to neuromodulation. Repetitive transcranial magnetic stimulation (rTMS) has emerged as a potential novel treatment option for PCSs. To systematically review rTMS trials for the treatment of symptoms following concussion/mild traumatic brain injury (mTBI). We conducted a systematic review of Pubmed/Medline, Embase, and PsychINFO databases were searched up to May 19, 2020. Studies were included if they were prospective rTMS treatment studies of patients with mTBI/concussion. Variables including patient demographics, study design, rTMS protocol parameters, primary outcome measures, and efficacy data were extracted and qualitatively synthesized. rTMS methodology and study quality were also evaluated. Of the 342 studies identified, 11 met eligibility criteria and were included for synthesis. Forty-one percent of patients were female and age ranged from 18 to 65 (average age = 38.5 years). Post-concussive depression (seven studies) and headache (four studies) were the most commonly investigated symptoms. The majority of trials were sham-controlled with randomized control trial (RCT) designs, but all were small pilot samples (n < 30). Methodological heterogeneity and a low number of identified trials precluded quantitative meta-analysis. Regarding rTMS for post-concussive depression, positive results were found in two out of four studies with depression as a primary outcome, and all three studies that assessed depression as a secondary outcome. All four rTMS studies for post-concussive headache reported positive results. rTMS for the treatment of concussion/mTBI shows promising preliminary results for post-concussive depression and headache, symptoms that otherwise have limited effective treatment options. More studies with larger sample sizes are needed to further establish potential efficacy.

Sections du résumé

BACKGROUND BACKGROUND
Post-concussive symptoms (PCSs) are common, disabling, and challenging to manage. Evolving models of concussion pathophysiology suggest evidence of brain network dysfunction that may be amenable to neuromodulation. Repetitive transcranial magnetic stimulation (rTMS) has emerged as a potential novel treatment option for PCSs.
OBJECTIVES OBJECTIVE
To systematically review rTMS trials for the treatment of symptoms following concussion/mild traumatic brain injury (mTBI).
MATERIALS AND METHODS METHODS
We conducted a systematic review of Pubmed/Medline, Embase, and PsychINFO databases were searched up to May 19, 2020. Studies were included if they were prospective rTMS treatment studies of patients with mTBI/concussion. Variables including patient demographics, study design, rTMS protocol parameters, primary outcome measures, and efficacy data were extracted and qualitatively synthesized. rTMS methodology and study quality were also evaluated.
RESULTS RESULTS
Of the 342 studies identified, 11 met eligibility criteria and were included for synthesis. Forty-one percent of patients were female and age ranged from 18 to 65 (average age = 38.5 years). Post-concussive depression (seven studies) and headache (four studies) were the most commonly investigated symptoms. The majority of trials were sham-controlled with randomized control trial (RCT) designs, but all were small pilot samples (n < 30). Methodological heterogeneity and a low number of identified trials precluded quantitative meta-analysis. Regarding rTMS for post-concussive depression, positive results were found in two out of four studies with depression as a primary outcome, and all three studies that assessed depression as a secondary outcome. All four rTMS studies for post-concussive headache reported positive results.
CONCLUSIONS CONCLUSIONS
rTMS for the treatment of concussion/mTBI shows promising preliminary results for post-concussive depression and headache, symptoms that otherwise have limited effective treatment options. More studies with larger sample sizes are needed to further establish potential efficacy.

Identifiants

pubmed: 33184973
doi: 10.1111/ner.13319
pii: S1094-7159(21)06200-0
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

803-812

Informations de copyright

© 2020 International Neuromodulation Society.

Références

Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation 2007;22:341-353. https://doi.org/10.3233/NRE-2007-22502.
Dewan MC, Rattani A, Gupta S et al. Estimating the global incidence of traumatic brain injury. J Neurosurg 2018;130:1080-1097. https://doi.org/10.3171/2017.10.JNS17352.
Voss JD, Connolly J, Schwab KA, Scher AI. Update on the epidemiology of concussion/mild traumatic brain injury. Curr Pain Headache Rep 2015;19:32.
Langer L, Levy C, Bayley M. Increasing incidence of concussion: true epidemic or better recognition? J Head Trauma Rehabil 2020;35:E60-E66. https://doi.org/10.1097/HTR.0000000000000499.
McMahon P, Hricik A, Yue JK et al. Symptomatology and functional outcome in mild traumatic brain injury: results from the prospective TRACK-TBI study. JAMA Neurol 2014;31:26-33. https://doi.org/10.1089/neu.2013.2984.
Mayer AR, Quinn DK, Master CL. The spectrum of mild traumatic brain injury: a review. Neurology 2017;89:623-632. https://doi.org/10.1212/WNL.0000000000004214.
Suhr JA, Gunstad J. Postconcussive symptom report: the relative influence of head injury and depression. J Clin Exp Neuropsychol 2002;24:981-993. https://doi.org/10.1076/jcen.24.8.981.8372.
Guerin F, Kennepohl S, Leveille G, Dominique A, McKerral M. Vocational outcome indicators in atypically recovering mild TBI: a post-intervention study. NeuroRehabilitation 2006;21:295-303. https://doi.org/10.3233/NRE-2006-21404.
Stulemeijer M, Van der Werf S, Borm GF, Vos PE. Early prediction of favourable recovery 6 months after mild traumatic brain injury. J Neurol Neurosurg Psychiatry 2008;79:936-942. https://doi.org/10.1136/jnnp.2007.131250.
Cooper DB, Bunner AE, Kennedy JE et al. Treatment of persistent post-concussive symptoms after mild traumatic brain injury: a systematic review of cognitive rehabilitation and behavioral health interventions in military service members and veterans. Brain Imaging Behav 2015 Sep 1;9:403-420. https://doi.org/10.1007/s11682-015-9440-2.
Makdissi M, Schneider KJ, Feddermann-Demont N et al. Approach to investigation and treatment of persistent symptoms following sport-related concussion: a systematic review. Br J Sports Med 2017;51:958-968. https://doi.org/10.1136/bjsports-2016-097470.
Burke MJ, Fralick M, Nejatbakhsh N, Tartaglia MC, Tator CH. In search of evidence-based treatment for concussion: characteristics of current clinical trials. Brain Inj 2015;29:300-305. https://doi.org/10.3109/02699052.2014.974673.
Silverberg ND, Duhaime AC, Iaccarino MA. Mild traumatic brain injury in 2019-2020. JAMA 2020;323:177-178. https://doi.org/10.1001/jama.2019.18134.
Churchill NW, Hutchison MG, Graham SJ, Schweizer TA. Mapping brain recovery after concussion: from acute injury to 1 year after medical clearance. Neurology 2019;93:e1980-e1992. https://doi.org/10.1212/WNL.0000000000008523.
Brunoni AR, Chaimani A, Moffa AH et al. Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis. JAMA Psych 2017;74:143-152. https://doi.org/10.1001/jamapsychiatry.2016.3644.
Lipton RB, Dodick DW, Silberstein SD et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol 2010;9:373-380. https://doi.org/10.1016/S1474-4422(10)70054-5.
Carmi L, Tendler A, Bystritsky A et al. Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial. Am J Psychiatry 2019;176:931-938. https://doi.org/10.1176/appi.ajp.2019.18101180.
Walburn J, Gray R, Gournay K, Quraishi S, David AS. Systematic review of patient and nurse attitudes to depot antipsychotic medication. Br J Psychiatry 2001;179:300-307. https://doi.org/10.1192/bjp.179.4.300.
Pollak TA, Nicholson TR, Edwards MJ, David AS. A systematic review of transcranial magnetic stimulation in the treatment of functional (conversion) neurological symptoms. J Neurol Neurosurg Psychiatry 2014;85:191-197. https://doi.org/10.1136/jnnp-2012-304181.
Rao V, Bechtold K, McCann U et al. Low-frequency right repetitive transcranial magnetic stimulation for the treatment of depression after traumatic brain injury: a randomized sham-controlled pilot study. J Neuropsychiatry Clin Neurosci 2019;31:306-318. https://doi.org/10.1176/appi.neuropsych.17110338.
Siddiqi SH, Trapp NT, Hacker CD et al. Repetitive transcranial magnetic stimulation with resting-state network targeting for treatment-resistant depression in traumatic brain injury: a randomized, controlled, double-blinded pilot study. J Neurotrauma 2019;36:1361-1374. https://doi.org/10.1089/neu.2018.5889.
Hoy KE, McQueen S, Elliot D, Herring SE, Maller JJ, Fitzgerald PB. A pilot investigation of repetitive transcranial magnetic stimulation for post-traumatic brain injury depression: safety, tolerability, and efficacy. J Neurotrauma 2019;36:2092-2098. https://doi.org/10.1089/neu.2018.6097.
Lee SA, Kim MK. Effect of low frequency repetitive transcranial magnetic stimulation on depression and cognition of patients with traumatic brain injury: a randomized controlled trial. Med Sci Monit 2018;24:8789-8794. https://doi.org/10.12659/MSM.911385.
Leung A, Metzger-Smith V, He Y et al. Left dorsolateral prefrontal cortex rTMS in alleviating MTBI related headaches and depressive symptoms. Neuromodulation 2018;21:390-401. https://doi.org/10.1111/ner.12615.
Leung A, Fallah A, Shukla S et al. rTMS in alleviating mild TBI related headaches-a case series. Pain Phys 2016;19:E347-E354.
Leung A, Shukla S, Fallah A et al. Repetitive transcranial magnetic stimulation in managing mild traumatic brain injury-related headaches. Neuromodulation 2016;19:133-141. https://doi.org/10.1111/ner.12364.
Stilling J, Paxman E, Mercier L et al. Treatment of persistent post-traumatic headache and post-concussion symptoms using repetitive transcranial magnetic stimulation: a pilot, double-blind, randomized controlled trial. J Neurotrauma 2020;37:312-323. https://doi.org/10.1089/neu.2019.6692.
Koski L, Kolivakis T, Yu C, Chen JK, Delaney S, Ptito A. Noninvasive brain stimulation for persistent postconcussion symptoms in mild traumatic brain injury. J Neurotrauma 2015;32:38-44. https://doi.org/10.1089/neu.2014.3449.
Moussavi Z, Suleiman A, Rutherford G et al. A pilot randomised double-blind study of the tolerability and efficacy of repetitive transcranial magnetic stimulation on persistent post-concussion syndrome. Sci Rep 2019;9:1-5. https://doi.org/10.1038/s41598-019-41923-6.
Choi GS, Kwak SG, Lee HD, Chang MC. Effect of high-frequency repetitive transcranial magnetic stimulation on chronic central pain after mild traumatic brain injury: a pilot study. J Rehabil Med 2018;50:246-252. https://doi.org/10.2340/16501977-2321.
Fox MD, Buckner RL, White MP, Greicius MD, Pascual-Leone A. Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. Biol Psychiatr 2012;72:595-603. https://doi.org/10.1016/j.biopsych.2012.04.028.
Burke MJ, Fried PJ, Pascual-Leone A. Transcranial magnetic stimulation: neurophysiological and clinical applications. Handbook of clinical neurology. Volume 163 Cambridge, MA: Elsevier, 2019; p. 73-92. https://doi.org/10.1016/B978-0-12-804281-6.00005-7.
Chen JK, Johnston KM, Petrides M, Ptito A. Neural substrates of symptoms of depression following concussion in male athletes with persisting postconcussion symptoms. Arch Gen Psychiatr 2008;65:81-89. https://doi.org/10.1001/archgenpsychiatry.2007.8.
Fann JR, Hart T, Schomer KG. Treatment for depression after traumatic brain injury: a systematic review. J Neurotrauma 2009;26:2383-2402. https://doi.org/10.1089/neu.2009.1091.
Siddiqi SH, Taylor SF, Cooke D, Pascual-Leone A, George MS, Fox MD. Distinct symptom-specific treatment targets for circuit-based neuromodulation. Am J Psychiatr 2020;177:435-446. https://doi.org/10.1176/appi.ajp.2019.19090915.
Downar J, Daskalakis ZJ. New targets for rTMS in depression: a review of convergent evidence. Brain Stimul 2013;6:231-240. https://doi.org/10.1016/j.brs.2012.08.006.
Dunlop K, Gaprielian P, Blumberger D et al. MRI-guided dmPFC-rTMS as a treatment for treatment-resistant major depressive disorder. J Vis Exp 2015;11:e53129. https://doi.org/10.3791/53129.
Dunlop K, Sheen J, Schulze L et al. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: a three-arm, blinded, randomized controlled trial. Brain Stimul 2020;13:337-340. https://doi.org/10.1002/eat.22764.
Nelson LD, Tarima S, LaRoche AA et al. Preinjury somatization symptoms contribute to clinical recovery after sport-related concussion. Neurology 2016;86:1856-1863. https://doi.org/10.1212/WNL.0000000000002679.
Iverson GL, Gardner AJ, Terry DP et al. Predictors of clinical recovery from concussion: a systematic review. Br J Sports Med 2017;51:941-948. https://doi.org/10.1136/bjsports-2017-097729.
Ashina H, Porreca F, Anderson T et al. Post-traumatic headache: epidemiology and pathophysiological insights. Nat Rev Neurol 2019;15:607-617. https://doi.org/10.1038/s41582-019-0243-8.
Minen MT, Boubour A, Walia H, Barr W. Post-concussive syndrome: a focus on post-traumatic headache and related cognitive, psychiatric, and sleep issues. Curr Neurol Neurosci Rep 2016;16:100. https://doi.org/10.1007/s11910-016-0697-7.
Starling AJ, Tepper SJ, Marmura MJ et al. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE study). Cephalalgia 2018;38:1038-1048. https://doi.org/10.1177/0333102418762525.
Burke MJ, Joutsa J, Cohen AL et al. Mapping migraine to a common brain network. Brain 2020;143:541-553. https://doi.org/10.1093/brain/awz405.
Ansado J, Blunt A, Chen JK, Koski L, Ptito A. Impact of non-invasive brain stimulation on transcallosal modulation in mild traumatic brain injury: a multimodal pilot investigation. Brain Inj 2019;33:1021-1031. https://doi.org/10.1080/02699052.2019.1605620.
Luber B, Lisanby SH. Enhancement of human cognitive performance using transcranial magnetic stimulation (TMS). Neuroimage 2014;85:961-970. https://doi.org/10.1016/j.neuroimage.2013.06.007.
Neville IS, Zaninotto AL, Hayashi CY et al. Repetitive TMS does not improve cognition in patients with TBI: a randomized double-blind trial. Neurology 2019;93:e190-e199. https://doi.org/10.1212/WNL.0000000000007748.
Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci 2015;16:403-418. https://doi.org/10.1038/nrn3976.
Polich G, Iaccarino MA, Kaptchuk TJ, Morales-Quezada L, Zafonte R. Placebo effects in traumatic brain injury. J Neurotrauma 2018;35:1205-1212. https://doi.org/10.1089/neu.2017.5506.
Burke MJ, Kaptchuk TJ, Pascual-Leone A. Challenges of differential placebo effects in contemporary medicine: the example of brain stimulation. Ann Neurol 2019 Jan;85:12-20. https://doi.org/10.1002/ana.25387.
Davis NJ, Gold E, Pascual-Leone A, Bracewell RM. Challenges of proper placebo control for non-invasive brain stimulation in clinical and experimental applications. Eur J Neurosci 2013;38:2973-2977. https://doi.org/10.1111/ejn.12307.
Pink AE, Williams C, Alderman N, Stoffels M. The use of repetitive transcranial magnetic stimulation (rTMS) following traumatic brain injury (TBI): a scoping review. Neuropsychol Rehabil 2019;27:1-27. https://doi.org/10.1080/09602011.2019.1706585.
Andrews SC, Hoy KE, Enticott PG, Daskalakis ZJ, Fitzgerald PB. Improving working memory: the effect of combining cognitive activity and anodal transcranial direct current stimulation to the left dorsolateral prefrontal cortex. Brain Stimul 2011;4:84-89. https://doi.org/10.1016/j.brs.2010.06.004.
Donse L, Padberg F, Sack AT, Rush AJ, Arns M. Simultaneous rTMS and psychotherapy in major depressive disorder: clinical outcomes and predictors from a large naturalistic study. Brain Stimul 2018;11:337-345. https://doi.org/10.1016/j.brs.2017.11.004.

Auteurs

Adriano Mollica (A)

Harquail Centre for Neuromodulation and Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada.
Neuropsychiatry Program, Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

Farnaz Safavifar (F)

Harquail Centre for Neuromodulation and Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada.
Neuropsychiatry Program, Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

Michael Fralick (M)

Department of Medicine, Sinai Health System, University of Toronto, Toronto, ON, Canada.

Peter Giacobbe (P)

Harquail Centre for Neuromodulation and Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada.
Neuropsychiatry Program, Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

Nir Lipsman (N)

Harquail Centre for Neuromodulation and Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada.
Division of Neurosurgery, Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

Matthew J Burke (MJ)

Harquail Centre for Neuromodulation and Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada.
Neuropsychiatry Program, Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Berenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH